STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
- PMID: 15293608
- DOI: 10.1183/09031936.04.00080303
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease
Abstract
Activation of the transcription factor signal transducer and activator of transcription (STAT)-4 is critical for the differentiation of T-helper 1 cells/type-1 cytotoxic T-cells and the production of interferon (IFN)-gamma. Expression of STAT4, phospho-STAT4, IFN-gamma and T-box expressed in T-cells (T-bet) proteins in bronchial biopsies and bronchoalveolar lavage (BAL)-derived lymphocytes, obtained from 12 smokers with mild/moderate chronic obstructive pulmonary disease (COPD) (forced expiratory volume in one second (FEV1) 59 +/- 16% predicted), 14 smokers with normal lung function (FEV1 106 +/- 12% pred) and 12 nonsmoking subjects (FEV1 111 +/- 14% pred), was examined by immunohistochemistry and immunocytochemistry. In bronchial biopsies of COPD patients, the number of submucosal phospho-STAT4+ cells was increased (240 (22-406) versus 125 (0-492) versus 29 (0-511) cells mm(-2)) when compared with both healthy smokers and control nonsmokers, respectively. In smokers, phospho-STAT4+ cells correlated with the degree of airflow obstruction and the number of IFN-gamma+ cells. Similar results were seen in BAL (2.8 (0.2-5.9) versus 1.03 (0.09-1.6) versus 0.69 (0-2.3) lymphocytes x mL(-1) x 10(3)). In all smokers who underwent lavage, phospho-STAT4+ lymphocytes correlated with airflow obstruction and the number of IFNgamma+ lymphocytes. T-bet expression was not altered in bronchial biopsies and BAL-derived lymphocytes between the three groups. In conclusion, this study suggests that stable mild/moderate chronic obstructive pulmonary disease is associated with an active T-helper 1 cell/type-1 cytotoxic T-cell inflammatory process involving activation of signal transducer and activator of transcription 4 and interferon-gamma production.
Comment in
-
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease.Eur Respir J. 2004 Jul;24(1):3-5. doi: 10.1183/09031936.04.00043104. Eur Respir J. 2004. PMID: 15293596 No abstract available.
Similar articles
-
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.Clin Exp Allergy. 2004 Aug;34(8):1156-67. doi: 10.1111/j.1365-2222.2004.02030.x. Clin Exp Allergy. 2004. PMID: 15298554 Review.
-
Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2002 May 15;165(10):1404-9. doi: 10.1164/rccm.2107139. Am J Respir Crit Care Med. 2002. PMID: 12016104
-
Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10. Am J Respir Crit Care Med. 2006. PMID: 16474030 Free PMC article.
-
Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.Respir Res. 2010 Sep 24;11(1):128. doi: 10.1186/1465-9921-11-128. Respir Res. 2010. PMID: 20863413 Free PMC article.
-
Type I interferons and T helper development.Immunol Today. 2000 Oct;21(10):484-9. doi: 10.1016/s0167-5699(00)01710-2. Immunol Today. 2000. PMID: 11071526 Review. No abstract available.
Cited by
-
Transcriptomic characterization of the human segmental endotoxin challenge model.Sci Rep. 2024 Jan 19;14(1):1721. doi: 10.1038/s41598-024-51547-0. Sci Rep. 2024. PMID: 38242945 Free PMC article.
-
T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease.Clin Exp Immunol. 2009 Mar;155(3):466-75. doi: 10.1111/j.1365-2249.2008.03835.x. Clin Exp Immunol. 2009. PMID: 19220836 Free PMC article.
-
Systems biology coupled with label-free high-throughput detection as a novel approach for diagnosis of chronic obstructive pulmonary disease.Respir Res. 2009 Apr 22;10(1):29. doi: 10.1186/1465-9921-10-29. Respir Res. 2009. PMID: 19386108 Free PMC article. Review.
-
Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease.Transl Res. 2016 Jan;167(1):192-203. doi: 10.1016/j.trsl.2015.08.004. Epub 2015 Aug 20. Transl Res. 2016. PMID: 26334389 Free PMC article. Review.
-
LincRNA-Cox2 Regulates Smoke-induced Inflammation in Murine Macrophages.Am J Respir Cell Mol Biol. 2023 May;68(5):511-522. doi: 10.1165/rcmb.2022-0413OC. Am J Respir Cell Mol Biol. 2023. PMID: 36657060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous